summit study tirzepatide hfpef trial In pts wiht HFpEF and obesity, tirzepatide (Mounjaro®) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in trial https://t.co/8ZHm4gySiL Tirzepatide vs Semaglutide 2026: 22%
Pay in 4 interest-free payments of $6.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
















/assets/production/practices/52dfaec20b2342223cd4011f8bcdf3c234876a65/images/2830634.png)










